ISFT evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-14T13:56:16.528145+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 5342198000.0
- net_income
- 132770000.0
- operating_cash_flow
- 178653000.0
- free_cash_flow
- 178653000.0
- total_assets
- 3231469000.0
- total_liabilities
- 568357000.0
- total_equity
- 2663112000.0
- cash
- 46742000.0
- total_debt
- 172915000.0
- revenue_growth
- 0.05328555934350132
- earnings_growth
- 0.04666929444225465
- net_margin
- 0.02485306609751267
- roe
- 0.049855206990918895
- debt_to_equity
- 0.06492967625845252
- cash_conversion
- 1.345582586427657
- free_cash_flow_margin
- 0.033441852960148614
- trailing_pe
- 1417.56
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-1469d7d0d6bd5fa55e8ffa49fe0b438dde40f0b3d0ad3af9c44efbb11624dff0
- Policy
- stock-decisions-v1
- Evidence bundle hash
- e52ec8746d034aa235f58689cfef7303392750c5fa35ec2241233cecfa5cb780
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 8d5e658071e84324b889f74101c291a3fcbdfb6c675237d75b2e548011983258
- daily-price: 394621440a5d129c40b09cbd6bb7eea4be1f3b0b256aac0db34b8bcb2ea21d89
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 97.91.
- The trailing 5-session price return was -4.14%.
- The trailing 20-session price return was 11.50%.
- The trailing 60-session price return was 30.08%.
- The trailing 250-session price return was -4.41%.
- Average cached traded value over twenty sessions was INR 14,048,426.
- The closing price was -9.03% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-14T13:56:16.528145+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.05328555934350132.
- The cached financial metric net margin is 0.02485306609751267.
- The cached financial metric roe is 0.049855206990918895.
- The cached financial metric debt to equity is 0.06492967625845252.
- The cached financial metric cash conversion is 1.345582586427657.
- The cached financial metric free cash flow margin is 0.033441852960148614.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.